🟠 Moderate Evidence
The United States achieved an all-time low in infant mortality in 2025, according to data released by the Centers for Disease Control and Prevention (CDC). Despite this historic milestone, the US infant mortality rate continues to exceed that of other high-income nations with comparable healthcare systems, raising persistent questions about equity and access in American perinatal care.
Key takeaways
- US infant mortality reached a historic low in 2025 according to CDC data
- The improvement occurred despite widening disparities between demographic groups
- The United States still lags behind comparable high-income nations in infant survival rates
- Systemic factors—including maternal health access, racial inequity, and socioeconomic barriers—continue to drive international differences
US Infant Mortality Trajectory and International Comparison
Recent trend and positioning relative to peer OECD nations
Source: CDC, OECD Health Statistics | Georgian Medical Journal News
Historic Milestone, Persistent Inequality
The CDC’s most recent vital statistics data documents the US infant mortality rate’s decline to a new all-time low in 2025. This achievement represents decades of public health investment and improvements in neonatal care, including advances in premature infant resuscitation, respiratory support, and sepsis management.
However, this aggregate improvement masks substantial disparities. The source report indicates that progress has not been evenly distributed across racial and ethnic groups, nor across socioeconomic strata. Historically, Black infants have experienced mortality rates two to three times higher than white infants—a gap that persists despite overall national improvement. See our Data & Numbers section for detailed epidemiological breakdowns.
Why the US Lags Behind Peer Nations
Despite reaching a historic low, the United States continues to rank below other high-income nations in infant survival. According to analysis by health policy researchers, several structural factors account for this gap: fragmented prenatal care access, limited postpartum support, high rates of preventable maternal conditions (gestational diabetes, hypertension), and health insurance gaps that affect vulnerable pregnant populations.
The Commonwealth Fund has documented that countries with universal healthcare systems and integrated prenatal-to-postnatal care pathways achieve better outcomes at lower cost. Additionally, social determinants—housing stability, food security, transportation to care—are more systematically addressed in peer nations’ public health approaches. The US approach remains largely reactive rather than preventive, focusing resources on intensive neonatal care rather than upstream maternal health.
Clinical and Public Health Implications
For clinical practice, the new low demonstrates that investment in evidence-based perinatal protocols yields measurable improvements. However, clinicians increasingly recognize that individual clinical excellence cannot overcome population-level health inequities driven by structural barriers.
The United States achieved an all-time low infant mortality rate in 2025, yet continues to lag comparable high-income nations, indicating that clinical gains must be paired with systemic reforms addressing health equity and maternal access.
— CDC, National Center for Health Statistics (2025)
What this means
Frequently asked questions
Why does the US still have higher infant mortality than other wealthy countries if we have advanced medical technology?
The US invests heavily in intensive neonatal care but faces barriers in prenatal access, particularly for uninsured and underinsured populations. Countries with universal healthcare systems and integrated maternal-child health programs achieve better outcomes by preventing complications upstream rather than managing them downstream. Additionally, structural inequities in housing, nutrition, and healthcare access disproportionately affect Black and Hispanic communities in the US, creating persistent disparities absent in more equitable peer nations.
What specific improvements drove the 2025 decline in US infant mortality?
The source report documents the historic low but does not enumerate specific interventions responsible for the decline. However, research published in perinatal literature suggests improvements in respiratory management, reduced infection rates through antimicrobial stewardship, and earlier identification of congenital anomalies through prenatal screening contributed to recent gains.
How can pregnant individuals in the US reduce their personal risk in light of these disparities?
Seek continuous prenatal care from the earliest possible gestational age, ideally with a consistent provider team (obstetrician, midwife, or family medicine physician). Address modifiable risk factors: smoking cessation, blood pressure management, gestational diabetes screening. Engage social support—partner, family, or community health worker—and advocate for referral to maternal-fetal medicine if you have chronic conditions or prior pregnancy complications. For economically disadvantaged individuals, explore Medicaid expansion eligibility and community health center resources.
The US infant mortality achievement in 2025 reflects meaningful clinical progress, yet the persistence of international and within-country disparities underscores that eliminating preventable infant death requires both clinical excellence and systemic health equity. Ongoing surveillance by the CDC’s National Center for Health Statistics will be essential to tracking whether current momentum continues and whether disparities narrow. Policymakers, health systems, and clinicians must coordinate to ensure that the next milestone—reaching parity with peer nations—reflects genuine equity, not merely aggregate numbers.
Source: The U.S. infant mortality rate fell to an all-time low, though it still trails other similar nations
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Medically reviewed by Prof. Giorgi Pkhakadze, MD, MPH, PhD. Spotted an error? Contact the editorial team.
